GenAI and LLMs in Pharma R&D Essentials from Tonex, Inc.

GenAI and LLMs in Pharma R&D Essentials

"GenAI and LLMs in Pharma R&D Essentials" introduces the use of generative AI and large language models in molecular design, literature mining, and lab automation. Participants gain practical skills in building secure AI workflows for early-stage drug research. Given the sensitivity of intellectual property in R&D pipelines, cybersecurity measures such as prompt filtering and model shielding are discussed to defend against data leakage and misuse.

Course Overview

Overall Proficiency Level

2 - Intermediate

Course Catalog Number

T101

Course Prerequisites

None

Training Purpose

Functional Development

Management Development

Specific Audience

All

Delivery Method

Online, Self-Paced

Online, Self-Paced

Learning Objectives

Understand the fundamental concepts of Generative AI and Large Language Models (LLMs).
Explore the applications of GenAI and LLMs in pharmaceutical R&D, including drug discovery and synthesis.
Analyze the potential of GenAI for accelerating research and reducing development costs.
Evaluate the ethical considerations and biases inherent in GenAI models.
Discuss the cybersecurity implications of using GenAI and LLMs, including data leakage, prompt injection attacks, and the generation of malicious code.

Framework Connections

The materials within this course focus on the NICE Framework Task, Knowledge, and Skill statements identified within the indicated NICE Framework component(s):

Competency Areas

Work Roles

Feedback

If you would like to provide feedback on this course, please e-mail the NICCS team at NICCS@mail.cisa.dhs.gov. Please keep in mind that NICCS does not own this course or accept payment for course entry. If you have questions related to the details of this course, such as cost, prerequisites, how to register, etc., please contact the course training provider directly. You can find course training provider contact information by following the link that says “Visit course page for more information...” on this page.